Search
GW-468816
go.drugbank.com/drugs/DB15099ExperimentalGW-468816 is under investigation in clinical trial NCT00218465 (Effectiveness of GW468816, an NMDA Glycine Site Antagonist, for Prevention of Relapse to Smoking).
Categories: Receptors, N-Methyl-D-Aspartate, antagonists & inhibitorsIGN101
go.drugbank.com/drugs/DB06500ExperimentalIGN101 is an antibody-based cancer vaccine directed against epithelial cancers. It consists of 500 ug 17-1A antibody adsorbed on aluminum hydroxide.
Aurodox
go.drugbank.com/drugs/DB04124ExperimentalAurodox is an antibiotic obtained from a streptomyces variant considered as possibly effective against streptococcus pyogenes infections. It may promote growth in poultry.
Fosigotifator
go.drugbank.com/drugs/DB19409InvestigationalFosigotifator is under investigation in clinical trial NCT05757141 (An Open-label Exploratory Study of ABBV-CLS-7262 Subjects With Vanishing White Matter Disease).
Naltalimide
go.drugbank.com/drugs/DB21082ExperimentalNaltalimide has a monoisotopic molecular weight of 472.2 Da.
Fadaltran
go.drugbank.com/drugs/DB21100ExperimentalFadaltran has a monoisotopic molecular weight of 419.23 Da.
Romurtide
go.drugbank.com/drugs/DB21196ExperimentalRomurtide has a monoisotopic molecular weight of 886.56 Da.
Nacartocin
go.drugbank.com/drugs/DB21214ExperimentalNacartocin has a monoisotopic molecular weight of 985.51 Da.
Hibenzate
go.drugbank.com/drugs/DB21247ExperimentalHibenzate has a monoisotopic molecular weight of 242.06 Da.
Temurtide
go.drugbank.com/drugs/DB21305ExperimentalTemurtide has a monoisotopic molecular weight of 522.22 Da.